A new vaccine could soon protect patients from returning skin cancer. In a large clinical trial, patients with high-risk melanoma given an experimental vaccine alongside an approved immunotherapy drug called...
The Verdict
ClassificationUnsure
ConfidenceHigh confidence
Analyzedtext
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/c45515b9-5979-40f6-95ce-6e37a3b6d62e)